Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
about
Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapyCT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive ReviewAblation techniques for primary and metastatic liver tumorsHepatocellular carcinoma: From clinical practice to evidence-based treatment protocolsRole of surgery in colorectal cancer liver metastasesCancer concepts and principles: primer for the interventional oncologist-part IIDevelopment of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panelA Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular CarcinomaGuide for diagnosis and treatment of hepatocellular carcinomaLocoregional treatment for hepatocellular carcinoma: The best is yet to come.Image-guided tumor ablation: emerging technologies and future directions.Thermal ablation of hepatocellular carcinoma.Percutaneous ablation for small hepatocellular carcinoma.Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology.Neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: where do we stand?Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer.Trends in the utilization and impact of radiofrequency ablation for hepatocellular carcinomaTemperature sensitive liposomes combined with thermal ablation: Effects of duration and timing of heating in mathematical models and in vivoRadiofrequency ablation of liver VX2 tumor: experimental results with MR diffusion-weighted imaging at 3.0TRadiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolizationChemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort.Percutaneous radiofrequency thermal ablation of primary and metastatic hepatic tumors: current concepts and review of the literature.Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinomaComparative effectiveness of radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinoma.Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma.Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.Research reporting standards for radioembolization of hepatic malignancies.Dual-energy CT after radiofrequency ablation of liver, kidney, and lung lesions: a review of features.Hepatocellular carcinoma: From diagnosis to treatment.Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.Differentiation of benign periablational enhancement from residual tumor following radio-frequency ablation using contrast-enhanced ultrasonography in a rat subcutaneous colon cancer model.Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).Gefitinib Synergizes with Irinotecan to Suppress Hepatocellular Carcinoma via Antagonizing Rad51-Mediated DNA-Repair.Hepatic tumor ablation with clustered microwave antennae: the US Phase II trial.Hepatocellular carcinoma: natural history, current management, and emerging tools.Switching bipolar hepatic radiofrequency ablation using internally cooled wet electrodes: comparison with consecutive monopolar and switching monopolar modes.Ultrasound-Guided Percutaneous Radiofrequency Ablation of Liver Tumors: How We Do It Safely and CompletelySingle hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection?Current status of multimodal & combination therapy for hepatocellular carcinoma.Therapeutic efficacy and safety of percutaneous ethanol injection with or without combined radiofrequency ablation for hepatocellular carcinomas in high risk locations
P2860
Q26745962-D5DADD0D-CF12-47B2-B5D3-91D53BBBA13EQ26770014-8B20088E-334A-49D9-8B04-3E9A7F282799Q26770019-BDCB56C6-39C8-4E32-9C49-9B1839F891BFQ26783881-55C5C776-91FB-42AF-8685-7A7E4A32E4CFQ26830444-AA15C192-20EF-4F47-B625-DFCAE5461709Q27010961-5B2E6424-01F2-4E1F-9DDF-7D0279E35E9DQ27014926-B11A7C33-02F3-4032-A911-6ED86E9E68D1Q28067517-98330917-BF99-4D8A-BE04-279B1807225FQ28084003-8DD216F8-3615-491E-8F05-44336AE123F1Q30400312-2437CF30-08F9-45D4-A661-2AE795F4C5CEQ30468191-15B67B5B-589D-40A0-BDCA-9CA4AB83A435Q33323261-2811EDCB-F58A-4115-B6E9-0D68578DD9F8Q33427579-E791B4F8-B18F-4C73-BE9C-E95C57DB0093Q33561375-2344D3F1-4166-4DC4-A26E-569D625F4DC8Q33594862-A064A2C7-1A87-4895-B2EF-3E8FABF0689DQ33682891-0A2CB6A2-E06B-4141-A603-17463F37E182Q33761751-58830C0A-704D-4D2F-ADA1-91FFC6A91DB4Q33788183-ED420E7F-0B0B-4FB5-BD37-A1C431CA2FABQ34015608-C623D309-F23C-4D9F-A73E-DFB3BA09ACD8Q34065098-8CE9EBC1-2DC2-42C9-8EE5-5956A0206A9AQ34168811-2143F056-FBF7-4480-9ADE-66998070E2ACQ34563371-E4ED63A2-DD93-4FDF-A289-5E618E7D29DDQ34681150-A1B78CF7-7947-4541-AF3D-B9B7A3F25E4EQ35033273-4754562F-9403-403E-88A9-D5CDE8E686F0Q35051942-8BEE2A33-8E73-4641-AA1C-2CF4CADFEF68Q35081063-F621C069-6737-4C16-9CC4-2AA8F14DC676Q35111887-71F72CBC-8818-40CE-ABCF-60927C47A834Q35650411-AE831E87-25D7-41F0-B3CA-E69AA19DB998Q35668716-07B01E46-6EAB-4F01-9FCD-40715B1ABBABQ35745085-9B08E334-41C5-4FD7-A3A9-85CAAA618B96Q35760144-50B7D247-C231-4962-AFF0-CCC8CB5635DEQ35819943-DC45DA31-8735-437D-988A-793548D49D28Q35890736-5B4606A3-3319-408D-84FB-764DB1B59D83Q36063466-6106FDBB-FFFD-4FF0-81D8-4CCD386783D3Q36171275-843347F7-1C8C-4764-B783-79CF92E51E6DQ36235400-09F23FCE-4BC2-4688-8203-A02B4E2427ADQ36279843-9BE077F5-6767-4D5F-A8D1-434AE79FB1A8Q36408339-1A53BCC8-2AD4-4962-AE05-F3DA91137DF9Q36436294-142AFA6F-EA5B-41DF-B7AD-93560FE5CC6BQ36662565-42A52B71-B942-4CC4-975C-11512A6C1401
P2860
Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Radiofrequency ablation of hep ...... nation of the explanted liver.
@ast
Radiofrequency ablation of hep ...... nation of the explanted liver.
@en
type
label
Radiofrequency ablation of hep ...... nation of the explanted liver.
@ast
Radiofrequency ablation of hep ...... nation of the explanted liver.
@en
prefLabel
Radiofrequency ablation of hep ...... nation of the explanted liver.
@ast
Radiofrequency ablation of hep ...... nation of the explanted liver.
@en
P2093
P1433
P1476
Radiofrequency ablation of hep ...... nation of the explanted liver.
@en
P2093
Charles Lassman
David S K Lu
Kathryn Murray
Myron J Tong
Piyaporn Limanond
Rafael G Amado
Steven S Raman
P304
P356
10.1148/RADIOL.2343040153
P407
P577
2005-01-28T00:00:00Z